These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19101947)

  • 1. International epidemiology of prostate cancer: geographical distribution and secular trends.
    Baade PD; Youlden DR; Krnjacki LJ
    Mol Nutr Food Res; 2009 Feb; 53(2):171-84. PubMed ID: 19101947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
    Valberg M; Grotmol T; Tretli S; Veierød MB; Moger TA; Devesa SS; Aalen OO
    Eur J Epidemiol; 2017 Jun; 32(6):511-520. PubMed ID: 27431530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International trends in prostate-cancer mortality in the "PSA ERA".
    Oliver SE; May MT; Gunnell D
    Int J Cancer; 2001 Jun; 92(6):893-8. PubMed ID: 11351313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.
    Quinn M; Babb P
    BJU Int; 2002 Jul; 90(2):162-73. PubMed ID: 12081758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
    Kelly SP; Anderson WF; Rosenberg PS; Cook MB
    Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer and prostate-specific antigen testing in New South Wales.
    Smith DP; Supramaniam R; Marshall VR; Armstrong BK
    Med J Aust; 2008 Sep; 189(6):315-8. PubMed ID: 18803534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rising incidence of prostate cancer in Scotland: increased risk or increased detection?
    Brewster DH; Fraser LA; Harris V; Black RJ
    BJU Int; 2000 Mar; 85(4):463-72; discussion 472-3. PubMed ID: 10691826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of screening on prostate cancer rates and trends.
    Mettlin C
    Microsc Res Tech; 2000 Dec; 51(5):415-8. PubMed ID: 11074610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer incidence and mortality trends among elderly and adult Europeans.
    Vercelli M; Quaglia A; Marani E; Parodi S
    Crit Rev Oncol Hematol; 2000 Aug; 35(2):133-44. PubMed ID: 10936470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
    Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
    J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
    Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
    J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
    Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
    Telesca D; Etzioni R; Gulati R
    Biometrics; 2008 Mar; 64(1):10-9. PubMed ID: 17501937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
    Feuer EJ; Merrill RM; Hankey BF
    J Natl Cancer Inst; 1999 Jun; 91(12):1025-32. PubMed ID: 10379965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.
    Negoita S; Feuer EJ; Mariotto A; Cronin KA; Petkov VI; Hussey SK; Benard V; Henley SJ; Anderson RN; Fedewa S; Sherman RL; Kohler BA; Dearmon BJ; Lake AJ; Ma J; Richardson LC; Jemal A; Penberthy L
    Cancer; 2018 Jul; 124(13):2801-2814. PubMed ID: 29786851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer incidence and mortality rates and trends in the United States and Canada.
    McDavid K; Lee J; Fulton JP; Tonita J; Thompson TD
    Public Health Rep; 2004; 119(2):174-86. PubMed ID: 15192905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database.
    Stephenson RA
    Urol Clin North Am; 2002 Feb; 29(1):173-81. PubMed ID: 12109343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Descriptive epidemiology of prostate cancer in Japan and Western countries].
    Wakai K
    Nihon Rinsho; 2005 Feb; 63(2):207-12. PubMed ID: 15714967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer in Western Australia: trends in incidence and mortality from 1985 to 1996.
    Threlfall TJ; English DR; Rouse IL
    Med J Aust; 1998 Jul; 169(1):21-4. PubMed ID: 9695697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine.
    Patasius A; Innos K; Barchuk A; Ryzhov A; Leja M; Misins J; Yaumenenka A; Smailyte G
    BMJ Open; 2019 Oct; 9(10):e031856. PubMed ID: 31601600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.